Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells

Prostate

Volumn 54, Issue 2, 2003, Pages 112-124

  Yeh, Jiun Yih ^a   Huang, William J ^a,b   Kan, Shu Fen ^a   Wang, Paulus S ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Calcium; Caspase; Prostatic neoplasm

Indexed keywords

ANDROGEN; BUFALIN; CALCIUM; CASPASE 3; CASPASE 9; CINOBUFAGIN; LACTATE DEHYDROGENASE; OUABAIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL PROLIFERATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUFANOLIDES; CALCIUM; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTRACELLULAR FLUID; MALE; MATERIA MEDICA; NA(+)-K(+)-EXCHANGING ATPASE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0037304261     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10172     Document Type: Article

References (45)

1. Rhim JS, Kung HF. Human prostate carcinogenesis. Crit Rev Oncog 1997;8:305-328.
2. Chang CK, Yu HJ, Chan KW, Lai MK. Secular trend and ageperiod cohort analysis of prostate cancer mortality in Taiwan. J Urol 1997;158:1845-1848.
3. Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate 1999;39:135-148.
4. Tilley WD, Buchanan G, Hickey TE, Bentel JM. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 1996;2:277-285.
5. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ. A controlled trial of leuprolide with and without flutamide in prostatic cancinoma. N Engl J Med 1989;321:419-424.
6. Teicher BA, Kakeji Y, Ara G, Herbts RS, Northey D. Prostate carcinoma response to cytotoxic therapy: In vivo resistance. In Vivo 1997;11:453-461.
7. Theyer G, Schirmbock M, Thalhammer T, Sherwood ER, Baumgartner G, Halmilton G. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. J Urol 1993;150:1544-1547.
8. Berlin JD, Propert KJ, Trump D, Wilding G, Hedes G, Glick J, Burch P, Keller A, Loehrer P. 5-Fluorouracil and leucovorin, therapy in patients with hormone refractory prostate cancer: An Eastern Cooperative Oncology Group phase II study (E1889). Am J Clin Oncol 1998;21:171-176.
9. 2+ increases and apoptosis in androgenindependent, metastatic human prostate adenocarcinoma cells. Cancer Res 2000;60:3807-3812.
10. Haux J. Digitoxin is a potential anticancer agent for several types of cancer. Med Hypoth 1999;53:543-548.
11. Hong Z, Chan K, Yeung HW. Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu-Shen-Wan, by liquid chromatography. J Pharm Pharmacol 1992;44:1023-1026.
12. Panesar NS. Bufalin radioimmunoassays: In search of the endogenous digitalis-like substance. J Immunoassay 1994;15:371- 391.
13. Bagrov AV, Roukoyatkina NI, Fedorova OV, Pinaev AG, Ukhanova MV. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad. Eur J Pharmacol 1993;234:165-172.
14. Eliades D, Swindall B, Johnston J, Pamnani H, Haddy F. Hemodynamic effects of bufalin in the anesthetized dog. Hypertension 1989;13:690-695.
15. Pamnani MB, Chen S, Bryant HJ, Schooley JF Jr., Eliades DC, Yuan CM, Haddy FJ. Effects of three sodium-potassium adenosine triphosphate inhibitors. Hypertension 1991;18:316-324.
16. Schmidt TA, Allen PD, Colucci WS, Marsh JD, Kjeldsen K. No adaptation to digitalisation as evaluated by digitalis receptor (Na, K-ATPase) quantification in explanted hearts from donor without heart disease and from digitalised recipients with endstage heart failure. Am J Cardiol 1993;70:110-114.
17. Jones DP, McConkey DJ, Nicotera P, Orrenius S. Calciumactivated DNA fragmentation in rat liver nuclei. J Biol Chem 1989;264:6398-6403.
18. Trump BF, Berezesky IK. Calcium mediated cell injury and cell death. FASEB J 1995;9:219-228.
19. Furaya Y, Lundmo P, Short AD, Gill DL, Isaacs JY. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 1984;44:3522-3529.
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
21. Stone KR, Micky DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978;21:274-281.
22. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
23. Chung TD, Yu JJ, Spiotto MT, Bartkowski M, Simons JW. Characterization of the role of IL-6 in the progression of prostate cancer cells. Prostate 1999;38:199-207.
24. Janssen T, Darro F, Petein M, Raviv G, Pasteels JL, Kiss R, Schulman CC. In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 1996;77:144-149.
25. Chen L, Zhang BH, Harris DC. Evidence suggesting that nitric oxide mediates iron-induced toxicity in cultured proximal tubule cells. Am J Physiol 1998;274:F18-F25.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
27. Steel RD, Torrie JH. Principles and procedures of statistics. 2nd edition. New York: McGraw-Hill; 1980.
28. Lange PH. Early detection for prostate cancer. J Natl Cancer Inst 1991;83:1199-1201.
29. Steams ME, Wang M. Type IV collagenase (M(r)72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 1993;53:878-883.
30. Hsing AW, Devesa SS, Jin F, Gao YT. Rising incidence of prostate cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 1998;7:83-84.
31. Hsieh TC, Wu JM. Effects of fenritinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression. Prostate 1997;33:97-104.
32. Stenkvist B. Is digitalis a therapy for breast carcinoma? Oncol Rep 1999;6:493-496.
33. Stenkvist B, Pengtsson E, Dahlqvist B, Eriksson O, Jarkrans T, Nordin B. Cardiac glycisides and breast cancer, revisited. N Engl J Med 1982;306:484.
34. +-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines. Radiat Oncol Invest 1998;6:109-119.
35. + ions. J Biochem 1999;126:278-286.
36. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium 1998;23:173-180.
37. Kidd VJ. Proteolytic activities that mediate apoptosis. Ann Rev Physiol 1998;60:533-573.
38. Zhivotovsky B, Hanson KP, Orrenius S. Back to the future: The role of cytochrome c in cell death. Cell Death Differ 1998;5:459-460.
39. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
40. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 1998;12:806-819.
41. Coffey RN, Watson RW, Fitzpatrick JM. Signaling for the caspases: Their role in prostate cell apoptosis. J Urol 2001;165:5-14.
42. Yeh JY, Huang WJ, Kan SF, Wang PS. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells. J Urol 2001;166:1937-1942.
43. Stoffer SS, Hynes KM, Jiang NS, Ryan RJ. Digoxin and abnormal serum hormone levels. JAMA 1973;225:1643-1644.
44. Lin H, Wang SW, Tsai SC, Chen JJ, Chiao YC, Lu CC, Huang WJ, Wang GJ, Chen CF, Wang PS. Inhibitory effect of digoxin on testosterone secretion through mechanisms involving decreases of cyclic AMP production and cytochrome P450scc activity in rat testicular interstitial cells. Brit J Pharmacol 1998;125:1635-1640.
45. Wang SW, Chiao YC, Tsai SC, Lu CC, Chen JJ, Shih HC, Chen YH, Lin H, Hwu CM, Wang PS. Inhibition of bufalin on pituitary and testicular function in rats. J Pharmacol Exp Ther 1997;283:528-532.